Mariko Kobayashi

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi et al. · Hepatology · 2012 · 709 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

Norio Akuta, Fumitaka Suzuki, Hitomi Sezaki et al. · Intervirology · 2005 · 268 citations

Life Sciences, Infectious Diseases, Microbiology +17

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

Norio Akuta, Fumitaka Suzuki, Yusuke Kawamura et al. · Journal of Hepatology · 2006 · 266 citations

Pharmacy, Infectious Diseases, Pharmacology +17

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin†

Norio Akuta, Fumitaka Suzuki, Miharu Hirakawa et al. · Hepatology · 2010 · 255 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Apolipoprotein E (ApoE) Isoform-dependent Lipid Release from Astrocytes Prepared from Human ApoE3 and ApoE4 Knock-in Mice

Jian-Sheng Gong, Mariko Kobayashi, Hideki Hayashi et al. · Journal of Biological Chemistry · 2002 · 213 citations · Full text

Life Sciences, Biochemistry, Neuroscience +13